Trial Profile
Comparative trial of efficacy and safety of cardosten, valsartan and their combination in patients with chronic heart failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2011
Price :
$35
*
At a glance
- Drugs Angiotensin II receptor antibody (Primary) ; Valsartan
- Indications Chronic heart failure
- Focus Therapeutic Use
- 07 Sep 2011 New trial record
- 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.